Correlation Between Puma Biotechnology and Agios Pharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Agios Pharm, you can compare the effects of market volatilities on Puma Biotechnology and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Agios Pharm.

Diversification Opportunities for Puma Biotechnology and Agios Pharm

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Puma and Agios is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Agios Pharm go up and down completely randomly.

Pair Corralation between Puma Biotechnology and Agios Pharm

Given the investment horizon of 90 days Puma Biotechnology is expected to generate 1.75 times less return on investment than Agios Pharm. In addition to that, Puma Biotechnology is 1.75 times more volatile than Agios Pharm. It trades about 0.1 of its total potential returns per unit of risk. Agios Pharm is currently generating about 0.32 per unit of volatility. If you would invest  4,608  in Agios Pharm on August 29, 2024 and sell it today you would earn a total of  1,302  from holding Agios Pharm or generate 28.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Puma Biotechnology  vs.  Agios Pharm

 Performance 
       Timeline  
Puma Biotechnology 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Puma Biotechnology demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Agios Pharm 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Agios Pharm are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating forward indicators, Agios Pharm displayed solid returns over the last few months and may actually be approaching a breakup point.

Puma Biotechnology and Agios Pharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Puma Biotechnology and Agios Pharm

The main advantage of trading using opposite Puma Biotechnology and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.
The idea behind Puma Biotechnology and Agios Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.